During the past decade, SP CSK im. prof. K. Gibinskiego SUM conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "SP CSK im. prof. K. Gibinskiego SUM" are "Colitis, Ulcerative" (3 trials), "Crohn's Disease" (1 trials), "Diabetic Macular Edema" (1 trials), "Macular Edema" (1 trials) and "Retinal Vein Occlusion" (1 trials). Many other conditions were trialed in "SP CSK im. prof. K. Gibinskiego SUM" in a lesser frequency.

Most popular intervention types in "SP CSK im. prof. K. Gibinskiego SUM" are "Drug" (5 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Aflibercept" (2 trials), "KSI-301" (2 trials), "Sham Procedure" (2 trials), "Adalimumab" (1 trials) and "Adalimumab placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "SP CSK im. prof. K. Gibinskiego SUM" are 5 trials for "All" genders.

Currently, there are NaN active trials in "SP CSK im. prof. K. Gibinskiego SUM". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in SP CSK im. prof. K. Gibinskiego SUM, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in SP CSK im. prof. K. Gibinskiego SUM, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".